Edwards Lifesciences Corporation Common Stock

Financials

Total de ativos 7.24 B8.5 B8.29 B9.36 B13.06 B13.7 B Total de passivos 2.45 B2.67 B2.49 B2.64 B2.99 B3.36 B Capital total 4.57 B5.84 B5.81 B6.72 B10.06 B10.34 B Total de passivos e patrimônio líquido 7.24 B8.5 B8.29 B9.36 B13.06 B13.7 B Dívida total 595 M595.7 M596.3 M597 M597.7 M598.3 M Dívida líquida 595 M595.7 M596.3 M597 M597.7 M-3.63 B

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

EW

Financials

Edwards Lifesciences Corporation Common Stock

Notícias

OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?

Diretor da Edwards Lifesciences vende US$ 2 mi em ações

Ação da Edwards Lifesciences atinge máxima de 52 semanas em US$ 87,89

Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth

S&P 500 Top Stock Gainers Today, 5/22/26 - TipRanks.com

Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

VP da Edwards Lifesciences vende US$ 47.279 em ações da empresa

Boston Scientific: Poised To Rebound With The Healthcare Sector, But When? (NYSE:BSX)

Vice-presidente corporativo da Edwards Lifesciences vende US$ 170.160 em ações

Edwards Lifesciences nomeia Doretta Mistras como nova CFO

Top Research Reports for Philip Morris, Honeywell & Starbucks